How Big Data Is Hoping To Power Predictive Analytics
Date : Jun 06, 2016 - 07:30 AM - 10:00 AMEvent URL : http://www.BostonEventsList.com/events/how-big-data-is-hoping-to-power-predictive-analytics-jun-2016
Organizer : New England Healthcare Executives Network Venue :
Location : Constant Contact - 1601 Trapelo Road, Waltham, MA 02451,
Waltham, MA , US, ZIP: 02451 Phone: (617) 834-2920
New England Healthcare Executive Meeting
June 6, 2016, 7:30AM to 10:00AM
How Big Data is Hoping to Power Predictive Analytics
Artificial Intelligence & Predictive Analytics:
Can Healthcare Really Utilize It?
LOCATION: Constant Contact, 1601 Trapelo Rd, Waltham,
MA
Directions and parking information located
at:
https://goo.gl/maps/WLRSf
Better decision making, advanced analytics and big data insights. Can deep learning algorithms rival human skills in detecting disease from radiological images, identify cancer in pathology reports or predict complications. Is it necessary for humans to spend time reviewing reports to determine if you’re sick or at risk? We are awash in oceans of data. We can’t do it all – but can technology and computers handle this? Is a human’s time is better spent helping other humans by providing them with better clinical care. Can artificial intelligence be leveraged to provide personalized treatments for people battling diseases like cancer and diabetes? The goal of this program is to show how artificial intelligence can sort through piles of raw data to provide real-time information and be leveraged to provide personalized treatments.
Moderator
Bob Phelps, Business Development Executive
Panelists:
Michael Fahey, Offering Manager for Exogenous Data, IBM Watson Health
Ravi Kuppuraj, PhD, MBA, Venture Leader, Connected Sensing and Wearables, Philips Healthcare
Niven R. Narain, Co-founder, President & CEO, BERG Health Neil Smith, Co-founder, Think Outcomes
Learning Objectives:
At the conclusion of the program, you will understand: How big data is hoping to power predictive analytics;
Who should pay for digital-health applications and services; What evidence of effectiveness should be required?
Who should attend:
CEOs, CMO, CTO, CFO, clinicians, technologists and business experts seeking an
understanding of how artificial intelligence, predictive analytics and big data can be harnessed in the practice of medicine as a predictive tool in the new healthcare environment.
Biographies:
Michael Fahey, Offering Manager for Exogenous Data, IBM Watson Health
Ravi Kuppuraj, PhD, MBA, Venture Leader, Connected Sensing and Wearables, Philips
Healthcare
Ravi heads the Connected Sensing and Wearables venture at Philips. Ravi is a medical
industry veteran, with over 20 years of experience in patient monitoring, and healthcare IT. Most recently, Ravi co-founded and served as the CTO at InfoBionic, where he led the development of MoMeTM - a cloud-based, universal patient monitoring solution with unprecedented analytics that allows physicians to quickly and accurately diagnose and treat patients. Before InfoBionic, Ravi served as the Vice President of Research and Development at Draeger Medical, a global
powerhouse in patient monitoring, anesthesia delivery, and respiration technology. Prior to that, Ravi headed R&D efforts at SpaceLabs Medical, in Seattle, where he was instrumental in driving the development of key technologies and products in patient monitoring solutions, and was the General Manager for their India operations. In addition, Ravi was involved with several
successful med-tech startups, including CardioNet, where he served as Director, ECG Analysis. Ravi holds an MBA from the University of North Carolina at Chapel Hill, a PhD and MS in
biomedical engineering from Louisiana Tech University and University of Miami respectively, and a BSEE from Bangalore University.
Niven R. Narain, Co-founder, President & CEO, BERG Health
Niven R. Narain is Co-Founder, President & CEO of Berg, a Boston-based biopharma company housing fully integrated discovery, clinical, analytics, and diagnostics divisions. Narain is keenly focused on making the healthcare industry more efficient by employing the flagship Interrogative Biology® platform he created which leverages leading-edge biological and clinical insight from patients. The platform merges biology with technology to represent a true Precision Medicine approach to understating patient populations with use of artificial intelligence to derive actionable drug targets, biomarkers, and health analytic information. Niven has overseen the development of a robust pipeline at Berg led by BPM 31510, an anticancer technology he discovered that targets the cancer metabolism being developed for solid tumors and skin cancer.
Narain was previously Director of Cutaneous Oncology & Therapeutics Research at the Miller School of Medicine, serves as Sr. Biopharma Advisor to Ocean Tomo in Chicago and serves on the Steering Committee for NASA on the Gene Lab/Mars Initiative. His work in cancer and health analytics has been featured in Forbes, Fortune, the Harvard Business Review, CNBC, Fox Business, Bloomberg, and RE/Code. He has been an invited speaker at the Aspen Ideas Festival, in addition to major healthcare conferences such as Bloomberg, The Economist, Financial Times, and the WIPO in Geneva. Narain served as a mentor to many high school, college, and graduate/medical students in the Intel, Upward Bound, and NIH Howard Hughes Medical Internship. He is a St. John’s University Boston Chapter alumni advisor and is an active member of the Trinity Church Boston.
A graduate of St. John’s University, NY in Biochemistry/Philosophy, Narain received his PhD training in cancer biology and clinical dermatology research at the Miller School of Medicine. Niven is a recipient of St. John’s University’s Charles Lacaillade Prize, the Sylvester Cancer Center Charles Gordon Zubrod Prize, and an NIH/NIDDK Award of Excellence and was honored by the Boston Business Journal 40 under 40 as one of the top leaders (2014). He is most
passionate in improving patient care and enabling patient access to the most innovative technologies in an effort to improve the healthcare ecosystem.
Neil Smith, Co- founder, Think Outcomes
Neil is responsible for leading our client solutions team to help clients solve their process-level, intellectual business challenges. He is also responsible for growing our partner network to enhance our critical thinking software infrastructure.
Working with clients through IBM, Oracle and mid-sized software organizations, Neil brings over 25 years of leadership as a solutions consultant in enterprise software, web architecture,
business intelligence and data management through his work with business and technology executives in the industrial sector, financial services, pharmaceutical, healthcare and CPG sectors. Neil has a track record of synthesizing sophisticated topics for which he constructs modern business and technology solutions.
Robert Phelps, Business Development Executive
He was a founding member of the team that drove Biosphere Medical’s success with the
introduction of microspheres for drug therapies and tumor management which was acquired by Merit Medical. Bob led the start-up ConforMIS patient–specific knee replacement revenues to quadruple in four years’ time and set the stage for further company development. Additionally he held senior executive commercial leadership positions within Biomet contributing to turning around the BTBS business unit, driving business development in joint replacements, spine, trauma, bracing and electrical stimulation products. Bob has led the commercial team at Johnson & Johnson’s Orthopedic business unit more than doubling revenues and contributing to the acquisition of DePuy. He also has an extensive financial background raising funds for start-ups and in corporate finance. Most recently he led the commercial efforts for a navigation-driven robotic knee technology.Bob has a BS from Rutgers University and an MBA from Rider University.
